Trial intelligence / Profile preview

Propofol-based TIVA versus propofol + sevoflurane anesthesia for nasopharyngeal secretions in ocular surgery

ACTRN12616001120460Phase 4Completed

Sponsor
Tri-Service General Hospital
Start
Oct 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of propofol and sevoflurane (2 arms), sponsored by Tri-Service General Hospital. Primary endpoint: Total volume of nasopharyngeal secretions. Started Oct 2015; status: completed.

02

Drugs

propofolsevoflurane

Beyond the preview

Go deeper on ACTRN12616001120460.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12616001120460.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call